OWC Pharmaceutical Research Corp (OWCP)

[Renee]

Yes, you are correct. The 10K is audited and thus should only cover the full fiscal year of 2016. 8K's are used for material events that are not, or cannot be included in a previous yearly (10K) or quarterly (10Q) Financials. Efficacy and IP protection updates that are not in the 10K would therefore be submitted in an 8K if the material events did not happen during the fiscal year 10K.

**** All 10K's and 10Q's do report the current Outstanding Shares as of the date the 10-K or 10Q is submitted to EDGAR, not at or for the end of the reporting period.